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ABSTRACT 
Objective: Dimethyl sulfate has been highlighted as potential genotoxic and carcinogenic impurity. A sensitive Headspace gas chromatography (HS-
GC) method with pre-column derivatization was developed and validated for the determination of dimethyl sulfate impurity in methoxsalen active 
pharmaceutical ingredient.  
Methods: HS-GC method on the column Agilent DB-5, 30m X 0.53 mm, film thickness 1.5 µm, with flame ionization detector (FID) was used. 
Derivatization reagent concentration, time of reaction and pH of the solution were optimized during method development. This analytical method 
was evaluated by performing method validation as per ICH guideline.  
Results: The proposed method was specific, linear, accurate, rugged and precise. The calibration curves showed good linearity over the 
concentration range of 0.5 μg/ml to 3.0 μg/ml and the correlation coefficient was 0.999. Method had very low limit of detection (LOD) and limit of 
quantification (LOQ) 2.0 μg/g and 5.0 μg/g respectively. Accuracy was observed within 98.1%–104.5%.  
Conclusion: The developed method was demonstrated to be accurate, robust and sensitive for the determination of dimethyl sulfate impurity in 
methoxsalen drug substance. 
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Methoxsalen is a naturally occurring photoactive substance found in 
the seeds of the Ammi majus (Umbelliferae) plant. It belongs to a 
group of compounds known as psoralens or furocoumarins [1]. The 
chemical name of methoxsalen is 9-methoxy-7H-furo [3,2-g] [1]-
benzopyran7-one. It has an empirical formula of C12H8O4 and a 
molecular weight of 216.19 g mole−1 
Methoxsalen is official drug substance in United State 
Pharmacopoeia (USP). Dimethyl sulphate is not controlled in the 
USP monograph [2]. During literature survey several analytical 
methods are found reported of estimation of dimethyl sulfate. 
Dimethyl sulfate is checked at workplace atmosphere by GC with 
electrolytic conductivity detector (sulphur mode) at trace level using 
stainless steel Chromosorb WHP column [13]. DMS is estimated at 
workplace atmosphere by thin layer chromatography (TLC) method 
derivatizing with 4-nitrophenol. The LOQ of DMS is reported 40 ppm 
which is very high because TLC technique has limitations in 
sensitivity point of view [14]. Quantification of dimethyl sulfate by 
GCMS is reported by derivatizing with pentafluorobenzenethiol. This 
report suggests that solution stability and diluent study need to be 
optimized and mass detector is necessary to get DMS sensitivity at 
trace level [15]. Few more methods are reported by extracting the 
DMS in a solvent and tested by GC-MS [16-20]. DMS quantification 
by ion chromatography technique with conductivity detector is also 
reported by separating ionic compounds using Allsep anion 
exchange column [21]. Literature suggests that to achieve such a low 
level of limit of quantification hyphenated techniques with 
sophisticated instruments like GC-MS or sulphur specific detector or 
LC with conductivity detector is required. It might hardly possible 
for quality control laboratory of pharmaceutical industry to perform 
the testing routinely with GC-MS because of the cost and 
maintenance of a mass detector is very high. So in present research, 
analytical method is developed to quantify the DMS in methoxsalen 
drug substance with flame ionization detector. Due to low sensitivity 
of FID, pre-column derivatization was tried to achieve the 
quantification of analyte at trace level. The proposed analytical 
method was validated as per International conference on 
harmonization guidelines ICH Q2-R1 [22].  
MATERIALS AND METHODS 
Method of analysis 
Instrumentation 
[2]. Photochemotherapy 
(PUVA) is treatment involving the use of psoralen, like methoxsalen, 
an exogenous photosensitizer followed by ultraviolet A (UVA) 
irradiation [3-5].  
The manufacturing process of methoxsalen is seven step syntheses. 
In synthetic stage five a key raw material dimethyl sulfate (DMS) is 
used as methylating agent. It is used mainly for converting active-
hydrogen compounds such as phenols, amines and thiols to the 
corresponding methyl derivatives. Dimethyl sulfate is probably 
carcinogenic to humans so IARC classified DMS in Group 2A. It is a 
potent genotoxic chemical which can directly alkylate DNA both in 
vitro and in vivo [6-8]. Because of the known carcinogenicity and 
genotoxicity, the presence of residual dimethyl sulfate in 
methoxsalen drug substance must be controlled as per European 
Medicines Agency (EMA), International Conference on 
Harmonization [9] and Food and Drug Administration (FDA) 
guidelines [10, 11]. EMA and FDA guidelines proposed the use of the 
“threshold of toxicological concern” (TTC) concept for the limit of 
genotoxic/carcinogenic impurities. The concentration limit, in ppm, 
of genotoxic impurity in drug substance, is the ratio of TTC in μg per 
day to the expected dose of drug substance in a gram per day. 
Considering the recommended daily maximum dose of 0.070 g 
methoxsalen per day [1, 12], dimethyl sulfate must be limited to less 
than 21.4 μg/g in drug substance. So it is necessary to develop 
sensitive, accurate and robust analytical method. 
Perkin Clarus-500 GC with headspace auto sampler and flame 
ionization detector (FID) using Total Chrome Navigator software. 
Refer chromatographic parameters as per given in table 1. 
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Table 1: Chromatography parameter 
Column DB-5, 30m X 0.53 mm, Film Thickness: 1.5 µm 
Oven Temperature  40 °C 
Oven Program  40 °C hold for 8.0 min, ramp-1 at 5 °C/min to 100 °C hold for 0 minute, ramp-2 at 20 °C/min to 250 °C 
hold for 5 minute, 
Detector  Flame Ionization Detector (FID) 
Detector temperature 280 °C 
Injector temperature 220 °C 
Carrier Gas Nitrogen 
Carrier Gas pressure 5.0 psi 
Run Time 32.50 min 
Headspace Conditions 
Oven Temperature 90 °C 
Sample Line Temperature 110 °C 
Transfer line Temp 120 °C 
Headspace Pressure 16 psi 
Pressurize time 3.0 min 
Inject time 0.20 min 
Withdraw time 0.5 min 
Thermostat time 30.0 min 
GC Cycle Time 46.0 min 
 
Chemical and reagents 
GC columns used of Agilent DB-5 of a dimension 30 meters, internal 
diameter 0.53 mm with film thickness 1.5 µm. Agilent DB-1 of a 
dimension 30 meters, internal diameter 0.53 mm with film thickness 
3 µm. Agilent DB-624 of a dimension 30 meters, internal diameter 
0.53 mm with film thickness 3 µm. Anisole standard was procured 
from AVRA synthesis of purity 99.5%, dimethyl sulfate from Finar 
Ltd. of purity 99.0%, dimethyl sulfoxide from Rankem, phenol from 
Rankem, sodium hydroxide from Merck and purified HPLC grade 
water was used in the experimentation. 
Solution preparation 
Diluent preparation: Accurately weighed and transferred 10.7 g of 
phenol and 5.0 g of sodium hydroxide into 500 ml volumetric flask 
and diluted up to the mark with premixed dimethyl sulfoxide: Water 
(1:1 v/v) mixture. It was sonicated for two minutes; shake for one 
minute again sonicated for two minutes. This solution is used as 
diluent for preparation of blank, standard solution and test solution. 
Standard stock solution A: Accurately weighed and transferred 
0.10 g of dimethyl sulfate standard into 100 ml volumetric flask 
containing 40 ml of diluent and diluted up to the mark with diluent, 
shake it for two minutes again sonicated for five minutes. 
Note: 1) Diluent should be ready before weighing of dimethyl sulfate 
standard. 
2) After transfer of dimethyl sulfate standard to 100 ml volumetric 
flask immediately dilute up to the mark with diluent.  
Standard stock solution B: Accurately transferred 1.0 ml of 
standard stock solution A in to 100 ml volumetric flask, added 
diluent and diluted up to the mark with diluent. Shake and mix well. 
Standard stock solution C: Accurately transferred 5.0 ml of 
standard stock solution B in to 25 ml volumetric flask, added diluent 
and diluted up to the mark with diluent. Shake and mix well. 
Blank preparation: In to a 20 ml GCHS vial added 2.0 ml of diluent 
and crimped the head space vial with septa, star spring and alumina 
cap. 
Standard solution: In to a 20 ml GCHS vial added 2.0 ml standard 
stock solution C and crimped the headspace vial with septa, star 
spring and alumina cap. 
Test preparation: Accurately weighed and transferred 0.2 g of a 
sample in to a 20 ml GCHS vial and added 2.0 ml of diluent and 
crimped the headspace vial with septa, star spring and alumina cap. 
Procedure 
Performed blank followed by standard solution six times, blank 
followed by two test preparations. Run the chromatograph for 32.5 
min and record the chromatogram. The retention time of dimethyl 
sulfate derivative i.e. anisole is 15.0 min. 
Acceptance criteria for system suitability 
% RSD of area of dimethyl sulfate peak in six replicate injections 
should not be more than 15.0. 
CALCULATION 
Calculated the content of dimethyl sulfate in ppm by formula given 
below 
(peak area of DMS in sample–peak area DMS in blank) × Conc. of std. 
in mg/ml x P x 10
(Avg. peak area of DMS in std.–peak area of DMS in blank) × Conc. of 
sample in mg/ml x 100 
6 
RESULTS  
Analytical method development 
Dimethyl sulfate is a volatile compound of boiling point 188⁰C and 
has no chromophores. For analysis of such a ultr-violet (UV) inactive 
volatile compound gas chromatography (GC) is a suitable 
technology. To quantify the analyte at parts per million (ppm) levels, 
the concentration of test solution is required more. If the large 
quantity of test solution is injected on GC column it may spoil in long 
term usage so head space technique is preferable over liquid 
injection. Sensitivity of flame ionization detector is not sufficient to 
detect dimethyl sulphate at such a low concentration. So to enhance 
the response of dimethyl sulphate it was decided to perform pre-
column derivatization technique. Considering all above properties of 
the compound and purpose of the requirement of method 
development, GC headspace pre-column derivatization method is 
developed with FID after optimizing chromatographic parameters. 
Methylation of phenol with DMS in presence of sodium hydroxide is 
reported in literature [23]. The derivatized complex of dimethyl 
sulphate and phenol is anisole which has considerable and sufficient 
response with FID. It has been reported that DMS can be degraded 
with sodium hydroxide solution (1 mol/l), sodium carbonate 
solution (1 mol/l), or ammonium hydroxide solution (1.5 mol/l). 
Complete destruction of undiluted DMS or DMS in solvents miscible 
with water (methanol, ethanol, dimethyl sulfoxide, dimethyl 
formamide, acetone) or solvents partially miscible or immiscible 
with water (toluene, p-xylene, benzene, 1-pentanol, ethyl acetate, 
chloroform, carbon tetrachloride, acetonitrile) [24]. So many 
attempts were made to stabilize the DMS in various solvents but it is 
observed that further after derivatization the area of anisole was 
found inconsistent and reducing gradually. The derivatization 
reaction mechanism is explained in fig. 1.  
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Fig. 1: Derivatization reaction mechanism and formation of 
anisole 
 
This is two step reactions and it gets complete at room temperature. 
Once the sodium phenoxide is formed it is found stable. So first 
sodium phenoxide is prepared by addition of phenol and sodium 
hydroxide at room temperature in aqueous dimethyl sulfoxide 
solution. This solution is used as a reagent blank, for preparation of 
DMS standard and test solution. After optimization of these steps the 
anisole derivative was found stable in solution form and further the 
method is found satisfying all validation parameters like linearity, 
solution stability and accuracy. Anisole reference standard was 
procured from Avra Synthesis and injected in proposed method of 
analysis. The retention time of anisole standard and derivatized 
dimethyl sulfate standard peaks are eluting exactly at same 
retention time 15.0 min. During method optimization various 
stationary phases of different polarity were used like DB-624 (6% 
cyanopropyl phenyl and 94% dimethylpolysiloxane), DB-1 (100% 
dimethylpolysiloxane) and DB-5 (5% diphenyl and 95% 
dimethylpolysiloxane). In DB-624 DMS was eluting very close to 
DMSO peak and with DB-1 column DMS peak tailing factor was more 
than 2.0. DB-5 column was selected because DMS peak was 
separated from DMSO with resolution more than 5.0 and peak was 
symmetrical. 
Analytical method validation 
Selectivity 
Selectivity is the ability of the method to determine accurately and 
specifically the analyte of interest in the presence of other 
components in a sample matrix that may be expected to be present 
in the sample matrix under the stated conditions. Selectivity of the 
method was evidenced by comparing blank, dimethyl sulfate, 
methoxsalen and all specified impurities separate injections. There 
is no interfering peak at the retention time of dimethyl sulfate is 
observed. Dimethyl sulfate is well resolved from all other specified 
solvent peaks which are used in the manufacturing process of 
methoxsalen. Selectivity of methanol, acetone, methylene chloride, 
n-hexane, ethyl acetate, toluene and benzene had been checked and 
found separated from dimethyl sulfate peak. Refer figure-2 and 3 of 
dimethyl sulfate standard solution and test solution chromatograms. 
 
 
Fig. 2: Dimethyl sulfate standard solution chromatogram 
 
 
Fig. 3: Test solution chromatogram of methoxsalen 
 
Solution stability 
Drug stability in the active pharmaceutical ingredients (API) is a 
function of storage conditions and chemical properties of the drug 
and its impurities. The solution stability till twenty-six hours of 
derivatized DMS had been checked by injecting standard solution. 
DMS standard solution was prepared fresh before injection and 
immediately injected and same solution was injected after twenty-
six hours. The peak area of DMS of freshly prepared standard 
solution was observed 280527 and after twenty six hours it was 
272834. No significant change in area was observed after twenty-six 
hours. 
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LOD and LOQ 
The limit of detection (LOD) is the lowest concentration of the 
analyte in a sample that can be detected but not necessary 
quantified. The obtained LOD values of specified impurities and API 
is discussed. 
LOD = 3.3 × σ/S 
The limit of quantitation (LOQ) is the lowest concentration or 
amount of the analyte that can be determined quantitatively within 
an acceptable level of repeatability precision and trueness. 
LOQ = 10.0 × σ/S 
Where σ = the standard deviation of the response and S= slope of the 
calibration curve 
LOD and LOQ concentration are reported in parts per million (ppm) 
with respect to methoxsalen test concentration. LOD is 2.0 ppm and 
LOQ is 5.0 ppm. Precision of LOQ is checked by injecting six replicate 
injections. Relative standard deviation (RSD) of peak area of 
dimethyl sulfate at LOQ level was observed 5.4% which proves 
consistency and reproducibility of the method at trace level. 
Linearity 
Under the experimental conditions, the peak area vs. concentration 
plot for the proposed method was found to be linear over the range 
of LOQ level i.e. 25%, 50%, 100%, and 150% of the specified limit 
with a regression coefficient is 0.999. The regression coefficient (r2
 
) 
is more than 0.99 is generally considered as evidence of acceptable 
fit of the data to the regression line. Linearity plot is given in fig. 4. 
 
Fig. 4: Linearity plot of dimethyl sulfate derivative 
 
Accuracy 
Accuracy can be defined as the closeness of agreement between 
a test result and the accepted reference value. Accuracy of the 
method was determined by recovery study. Analytical method 
may be considered validated in terms of accuracy if the mean 
value is within±20% of the actual value. During recovery study 
methoxsalen API batch was analyzed and then dimethyl sulfate is 
spiked in the API at LOQ level, 100% and 150% with respect to 
the limit of dimethyl sulfate that is 21.4 ppm. The recovery was 
found 104.5%, 93.8% and 98.1% respectively which proves that 
the method is capable to quantify the analyte accurately and 
results will be reliable even at trace level. 
Ruggedness study 
The intra-laboratory tested behavior of an analytical process when small 
changes in the environment and/or operating condition are made. The 
ruggedness of the method was evaluated by estimating % RSD of 
derivatized DMS standard solution tested by two different analysts on 
different days. Validation batches were prepared by each analyst 
separately. % RSD of area of DMS peak in standard solutions of both 
analysts should not be more than 10%. Six replicates of diluted standard 
solution were injected by each analyst. Relative standard deviation of 
area of dimethyl sulfate was found 1.02% and 5.06% on two different 
days. Content of dimethyl sulfate in one API batch was tested on two 
different days and the results were found 1.6 ppm and 1.3 ppm 
respectively. Method validation summary is given in table 2. 
 
Table 2: Analytical method validation summary 
S. No. Parameter Acceptance criteria Results 
1 Selectivity DMS derivative peak should be well separated from all known and unknown 
impurities of methoxsalen. 
Method is selective 
2 Solution stability Report Result Solutions are stable up to 
24 h 
3 Limit of detection Report Result 2.0 ppm wrt test 
concentration 
4 Limit of quantification Report Result 5.0 ppm wrt test 
concentration 
5 LOQ precision %RSD for six replicates of LOQ level standard solutions is NMT: 10.0% RSD 5.4% 
6 Linearity Correlation: NLT 0.99 R2
7 
 0.999 
Accuracy Recovery should be between  
80% to 120%  
98.1% to 104.5% 
8 Method precision %RSD for results of six standard replicate is NMT: 10% RSD 1.02% 
9 Intermediate precision %RSD for results of twelve standard replicate (Method precision and 
Intermediate precision) is NMT: 10% 
RSD 3.5% 
Abbreviations: DMS is a dimethyl sulphate, h is hour, ppm is parts per million, wrt is with respect to, %RSD is percent relative standard deviation, 
LOQ is limit of quantification, NMT is not more than, NLT is not less than and R2 is correlation coefficient. 
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Dimethyl sulfate is used in the manufacturing process of 
methoxsalen. Since the dimethyl sulfate is known mutagenic and 
carcinogenic impurity it should not be detected in the medicinal 
product. As per ICH guideline the allowable intake of dimethyl 
sulfate is calculated considering maximum daily dose of 
methoxsalen. So the limit of dimethyl sulfate was found 21.4 ppm. 
Literature reveals that detection and quantification of DMS is 
possible with highly sophisticated techniques like GCMS which 
require skilled manpower and maintenance cost is also high. 
Derivatization techniques also reported but either specific detector 
were required along with LC or GC or many limitations during 
analysis were observed due to unstable formation of DMS derivative. 
The derivative complex is unstable in solution form. In this method 
the complex formed during pre-column derivatization i.e. anisole, 
after reacting with phenol is very stable. So fresh or immediate 
testing of the derivatized product was not required. To make the 
stable complex, first phenol was reacted with sodium which gives 
sodium phenoxide and this is used as diluent for preparation blank, 
standard, test and all other solutions for validation study. Sodium 
phenoxide is quite stable at room temperature that is later on 
reacting with DMS to form stable anisole. Solution stability was 
checked and found that the DMS derivative is stable till twenty-six 
hours. The stability of the derivatized complex is further confirmed 
during method validation recovery study. It was performed at three 
different levels from LOQ to 150%, and recovery was observed 
minimum 98.1% and maximum 104.5% which proves that the 
derivatized complex is very stable and quantifiable at such a trace 
level. The method was so sensitive that it could detect the analyte 
even at 2 ppm and can be quantified at 5 ppm which sufficient and 
very low level compared to the limit of the DMS genotoxic impurity. 
Linearity study indicated that area was directly proportional to 
concentration of the derivatized analyte with R2
CONCLUSION 
 0.999 in the 
concentration range of LOQ to 150% level with respect to the limit of 
the analyte. The method was further challenged with inter and intra-
laboratory changes in operation parameters which are possible 
during routine day to day testing as well as during technology 
transfer to another laboratory. Precision of the results was 
confirmed by performing the testing on different days and two 
different analysts with separate instruments and found that relative 
standard deviation was less than 10% that is the indication of 
reproducibility of the method at given laboratory conditions. 
Further, the method was successfully applied to three methoxsalen 
validation batches with dimethyl sulfate concentration levels were 
found far below the LOQ. 
In conclusion, quantification method was developed to check 
genotoxic process impurity dimethyl sulfate in methoxsalen drug 
substance. The proposed method was validated as per ICH guideline 
and checked accuracy and reliability of the result. The static head 
space GC-FID analytical method with pre-column derivatization 
satisfies all validation parameters like system suitability, precision, 
specificity, accuracy, linearity of detector response, ruggedness and 
robustness. It indicates that the method is stable and suitable for the 
quantification of dimethyl sulfate in methoxsalen. Hence, the 
validated method can be used for routine analysis of quantification 
of dimethyl sulfate in methoxsalen in quality control laboratories in 
the pharmaceutical industry. 
ACKNOWLEDGEMENT 
Thanks to the management of Wanbury Limited for constant 
support. 
AUTHORS CONTRIBUTIONS 
All authors contribute equally to this manuscript 
CONFLICT OF INTERESTS 
Author Ajit Anerao, Bhushan Patil and Nitin Pradhan declare that 
they have no conflict of interest. 
Ethical approval: This article does not contain any studies with 
human participants or animals performed by any of the authors. 
REFERENCES 
1. Rx List. Uvadex. Methoxsalen. 2016; Available from: 
http://www.rxlist.com/uvadex-drug.htm. [Last accessed on 01 
May 2018]  
2. United State Pharmacopoeia. Methoxsalen official monograph. 
USP 40; 2016. p. 5087-8.  
3. Shenoi S, Prabhu S. Photochemotherapy (PUVA) in psoriasis 
and vitiligo. Indian J Derm Vene Leprol 2014;80:497-504. 
4. Parrish J, Fitzpatrick T, Tanenbaum L, Pathak M. 
Photochemotherapy of psoriasis with oral methoxsalen and 
longwave ultraviolet light. New Engl J Med 1974;291:1207-11. 
5. Melski J, Tanenbaum L, Parrish J, Fitzpatrick T, Bleich H. Oral 
methoxsalen photochemo therapy for the treatment of psoriasis: 
a cooperative clinical trial. J Invest Derm 1977;68:328-35. 
6. IARC. Some pharmaceutical drugs. IARC Monogr Eval Carcinog 
Risk Chem Hum 1980;24:1–337. 
7. IARC. Genetic and related effects. An updating of selected IARC 
monographs from Volumes 1 to 42. IARC Monogr Eval Carcinog 
Risks Hum Suppl 1987;6b:1–729. 
8. IARC. Overall evaluations of carcinogenicity. An updating of 
IARC Monographs volumes 1 to 42. IARC Monogr Eval Carcinog 
Risks Hum Suppl. 1987;7a:1–440. 
9. ICH. M7(R1) Addendum to ICH M7. Assessment and Control of 
DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to 
Limit Potential Carcinogenic Risk; Application of the Principles 
of the ICH M7 Guidance to Calculation of Compound-Specific 
Acceptable Intakes. ICH Harmon Guid; 2017. 
10. ICH. Impurities in new drug substances Q3A (R2); 2006. 
11. FDA. U. S. Dept of Health and Human Services Food and Drug Adm. 
Guidance for Industry ANDAs: Impurities in Drug Substances; 
2009. 
12. Drugs. com. Methoxsalen dosage; 2016. Available from: 
https://www.drugs.com/dosage/methoxsalen.html. [Last accessed 
on 01 May 2018]. 
13. NIOSH. Manual of Analytical Methods (NMAM). Fourth Edition. 
DIMETHYL SULFATE. METHOD 2524; 1994. Available from: 
https://www.cdc.gov/niosh/docs/2003-154/pdfs/2524.pdf. 
[Last accessed on 01 May 2018] 
14. FEAIIG. Federation of the Employment Accidents Insurance 
Institutions of Germany. Centre for Accident Prevention and 
Occu Med. Method for the determination of dimethyl sulfate 
(DMS). Ana Met Air Monit Met 1997;5:75-105. Available from: 
http://onlinelibrary.wiley.com/doi/10.1002/3527600418.am
7778e0005/pdf. [Last accessed on 01 May 2018] 
15. Prabhu P. Trace level determination of residues of dimethyl sulfate 
and diethyl sulfate in pharmaceutical products by headspace gas 
chromatography and mass spectrometry following derivatization 
with pentafluorobenzenethiol. Experimental Notes Perkin Elmer; 
2015. Available from: http://www.perkinelmer.com/ CMSRe-
sources/Images/20130104_8-Trace-level-determination-residues 
of dimethyl sulfate.pdf. [Last accessed on 01 May 2018] 
16. Zheng J, Wayne A, Zhang S, Wittenberger S. Determination of 
low ppm levels of dimethyl sulfate in an aqueous soluble API 
intermediate using liquid–liquid extraction and GC–MS. J 
Pharma Biomed Anal 
17. Nalavade A, Sandhyakumari B, Ramakrishna K, Srinivasarao V. 
Development and evaluation of class-1 solvent 1, 2-
dichloroethane and dimethyl sulphate as a genotoxic impurity 
in sildenafil citrate drug substance by using GC-MS technique. 
Int J Pharm Pharma Sci 2014;6;552-5. 
2009;50:1054-9. 
18. Schäfer C, Zöllner P. Determination of trace levels of dimethyl 
sulfate in the presence of monomethyl sulfate by gas 
chromatography-mass spectrometry. J Chrom A 2013;4:10. 
19. Rahman M, Gullick D, Hoerner J, Bartlett M. 
20. 
Determination of 
genotoxic impurities monomethyl sulfate and dimethyl sulfate in 
active pharmaceutical ingredients. Anal Methods 2017;7:1112-8. 
Nanduri V, Reddy K, Adapa V, Ramakrishna K. Validated 
chromatographic methods for the determination of process related 
toxic impurities in pantoprazole sodium. Chromatographia 
2008;68:
21. Narendrakumar M, Krishna Reddy V, Sharma H, Kaleemullah T, 
Madhava Reddy P, John P, et al. Simple and sensitive ion 
481–4. 
Anerao et al. 
Int J Pharm Pharm Sci, Vol 10, Issue 8, 84-89 
 
89 
chromatography method for the simultaneous determination of 
dimethyl sulfate and diethyl sulfate contents in metoprolol 
tartrate drug substance. Chem Sin 2011;2:164-72. 
22. ICH. Validation of analytical procedures: Text and methodology 
Q2 (R1); 2005. 
23. Hiers G, Hager F. Anisole. Org Syn 1941;1;58;9;1929;12. 
Doi:10.15227/orgsyn.009.0012 
24. Lunn G, Sansone E. Validation of techniques for the 
destruction of dimethyl sulfate. Am Indu Hyg Assoc J 
 
1985;46:111-4.
